Roger G. Deeley

12.3k total citations · 4 hit papers
120 papers, 10.2k citations indexed

About

Roger G. Deeley is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Roger G. Deeley has authored 120 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Oncology, 48 papers in Pediatrics, Perinatology and Child Health and 37 papers in Molecular Biology. Recurrent topics in Roger G. Deeley's work include Drug Transport and Resistance Mechanisms (99 papers), Pharmacological Effects and Toxicity Studies (47 papers) and Trace Elements in Health (24 papers). Roger G. Deeley is often cited by papers focused on Drug Transport and Resistance Mechanisms (99 papers), Pharmacological Effects and Toxicity Studies (47 papers) and Trace Elements in Health (24 papers). Roger G. Deeley collaborates with scholars based in Canada, United States and United Kingdom. Roger G. Deeley's co-authors include Susan P.C. Cole, Elaine M. Leslie, Douglas W. Loe, Caroline E. Grant, Christopher J. Westlake, Kurt C. Almquist, David R. Hipfner, Qingcheng Mao, Mian Gao and Gerald M. Wilson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Roger G. Deeley

119 papers receiving 10.0k citations

Hit Papers

Multidrug resistance prot... 1994 2026 2004 2015 2004 1994 2006 1996 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger G. Deeley Canada 51 7.9k 3.4k 3.2k 2.0k 1.7k 120 10.2k
George L. Scheffer Netherlands 62 10.5k 1.3× 5.3k 1.6× 4.1k 1.3× 1.5k 0.8× 2.7k 1.5× 141 14.9k
Jörg König Germany 55 8.1k 1.0× 2.3k 0.7× 4.2k 1.3× 1.0k 0.5× 1.8k 1.0× 128 10.9k
Gabriele Jedlitschky Germany 50 5.1k 0.6× 2.1k 0.6× 2.4k 0.8× 860 0.4× 1.2k 0.7× 104 7.4k
Els Wagenaar Netherlands 53 10.1k 1.3× 4.3k 1.3× 5.0k 1.6× 900 0.5× 1.8k 1.0× 97 14.1k
R G Deeley Canada 40 5.3k 0.7× 3.6k 1.1× 1.7k 0.6× 763 0.4× 1.5k 0.8× 60 8.3k
Raymond Evers United States 52 5.8k 0.7× 2.8k 0.8× 2.7k 0.9× 756 0.4× 1.0k 0.6× 99 9.2k
I Pastan United States 29 8.4k 1.1× 4.7k 1.4× 2.6k 0.8× 543 0.3× 1.5k 0.8× 48 10.8k
Toshihisa Ishikawa Japan 47 4.4k 0.6× 3.1k 0.9× 1.5k 0.5× 870 0.4× 844 0.5× 156 7.7k
Anne T. Nies Germany 44 5.1k 0.6× 2.0k 0.6× 2.4k 0.8× 572 0.3× 1.2k 0.7× 91 7.3k
András Váradi Hungary 46 4.7k 0.6× 3.1k 0.9× 1.5k 0.5× 885 0.5× 1.1k 0.6× 116 8.1k

Countries citing papers authored by Roger G. Deeley

Since Specialization
Citations

This map shows the geographic impact of Roger G. Deeley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger G. Deeley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger G. Deeley more than expected).

Fields of papers citing papers by Roger G. Deeley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger G. Deeley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger G. Deeley. The network helps show where Roger G. Deeley may publish in the future.

Co-authorship network of co-authors of Roger G. Deeley

This figure shows the co-authorship network connecting the top 25 collaborators of Roger G. Deeley. A scholar is included among the top collaborators of Roger G. Deeley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger G. Deeley. Roger G. Deeley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deeley, Roger G., et al.. (2018). Structural Studies of Multidrug Resistance Protein 1 Using “Almost” Cysless Template. Drug Metabolism and Disposition. 46(6). 794–804. 3 indexed citations
2.
Rosenberg, Mark F., Curtis Oleschuk, Peng Wu, et al.. (2010). Structure of a human multidrug transporter in an inward-facing conformation. Journal of Structural Biology. 170(3). 540–547. 20 indexed citations
3.
Rothnie, Alice J., Richard Callaghan, Roger G. Deeley, & Susan P.C. Cole. (2006). Role of GSH in Estrone Sulfate Binding and Translocation by the Multidrug Resistance Protein 1 (MRP1/ABCC1). Journal of Biological Chemistry. 281(20). 13906–13914. 46 indexed citations
4.
Westlake, Christopher J., Susan P.C. Cole, & Roger G. Deeley. (2005). Role of the NH2-terminal Membrane Spanning Domain of Multidrug Resistance Protein 1/ABCC1 in Protein Processing and Trafficking. Molecular Biology of the Cell. 16(5). 2483–2492. 56 indexed citations
5.
Deeley, Roger G., et al.. (2005). Functional characterization of non-synonymous single nucleotide polymorphisms in the gene encoding human multidrug resistance protein 1 (MRP1/ABCC1). Pharmacogenetics and Genomics. 15(9). 647–657. 63 indexed citations
6.
Payen, Léa, et al.. (2005). Functional Interactions Between Nucleotide Binding Domains and Leukotriene C4 Binding Sites of Multidrug Resistance Protein 1 (ABCC1). Molecular Pharmacology. 67(6). 1944–1953. 22 indexed citations
7.
Conseil, Gwenaëlle, Roger G. Deeley, & Susan P.C. Cole. (2005). Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters. Pharmacogenetics and Genomics. 15(8). 523–533. 66 indexed citations
8.
Koike, Koji, Gwenaëlle Conseil, Elaine M. Leslie, Roger G. Deeley, & Susan P.C. Cole. (2004). Identification of Proline Residues in the Core Cytoplasmic and Transmembrane Regions of Multidrug Resistance Protein 1 (MRP1/ABCC1) Important for Transport Function, Substrate Specificity, and Nucleotide Interactions. Journal of Biological Chemistry. 279(13). 12325–12336. 59 indexed citations
10.
Haimeur, Anass, et al.. (2004). Mutational Analysis of Ionizable Residues Proximal to the Cytoplasmic Interface of Membrane Spanning Domain 3 of the Multidrug Resistance Protein, MRP1 (ABCC1). Journal of Biological Chemistry. 279(37). 38871–38880. 39 indexed citations
12.
Zhang, Dawei, et al.. (2003). Functional Importance of Polar and Charged Amino Acid Residues in Transmembrane Helix 14 of Multidrug Resistance Protein 1 (MRP1/ABCC1). Journal of Biological Chemistry. 278(46). 46052–46063. 41 indexed citations
13.
Haimeur, Anass, Roger G. Deeley, & Susan P.C. Cole. (2002). Charged Amino Acids in the Sixth Transmembrane Helix of Multidrug Resistance Protein 1 (MRP1/ABCC1) Are Critical Determinants of Transport Activity. Journal of Biological Chemistry. 277(44). 41326–41333. 66 indexed citations
14.
Kauffmann, Hans-Martin, Ken‐ichi Ito, Elaine M. Leslie, et al.. (2002). A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance. Pharmacogenetics. 12(4). 321–330. 87 indexed citations
15.
Kurz, Ebba U., Susan P.C. Cole, & Roger G. Deeley. (2001). Identification of DNA–Protein Interactions in the 5′ Flanking and 5′ Untranslated Regions of the Human Multidrug Resistance Protein (MRP1) Gene: Evaluation of a Putative Antioxidant Response Element/AP-1 Binding Site. Biochemical and Biophysical Research Communications. 285(4). 981–990. 45 indexed citations
16.
Ito, Ken‐ichi, et al.. (2001). Mutation of a Single Conserved Tryptophan in Multidrug Resistance Protein 1 (MRP1/ABCC1) Results in Loss of Drug Resistance and Selective Loss of Organic Anion Transport. Journal of Biological Chemistry. 276(19). 15616–15624. 139 indexed citations
17.
Leslie, Elaine M., Ken-ichi Ito, Pramod Upadhyaya, et al.. (2001). Transport of the β-O-Glucuronide Conjugate of the Tobacco-specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the Multidrug Resistance Protein 1 (MRP1). Journal of Biological Chemistry. 276(30). 27846–27854. 132 indexed citations
18.
Loe, Douglas W., Curtis Oleschuk, Roger G. Deeley, & Susan P.C. Cole. (2000). Structure–Activity Studies of Verapamil Analogs That Modulate Transport of Leukotriene C4 and Reduced Glutathione by Multidrug Resistance Protein MRP1. Biochemical and Biophysical Research Communications. 275(3). 795–803. 40 indexed citations
19.
Hipfner, David R., Kurt C. Almquist, Elaine M. Leslie, et al.. (1997). Membrane Topology of the Multidrug Resistance Protein (MRP). Journal of Biological Chemistry. 272(38). 23623–23630. 184 indexed citations
20.
Canitrot, Yvan, et al.. (1996). Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochemical Pharmacology. 52(7). 967–977. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026